Jumpcan Pharmaceutical Group Co Ltd – based in Taizhou city, in China's East Jiangsu province – was included in the list of innovative leading companies of Jiangsu province in September 2022, by the Jiangsu Provincial Department of Science and Technology.
It is a national high-tech enterprise group, a National Torch Program pharmaceutical industry backbone enterprise, is in the list of the top 100 national pharmaceutical industry companies and is a company that is on the Shanghai Stock Exchange A-share list.
It focuses on R&D, manufacturing and trading of Chinese traditional medicine, Western medicine, daily-use chemicals based on Chinese traditional medicine and on Chinese medicine health products.
The group has a raft of subsidiaries including Shanghai Jijia Investment Co Ltd, Tianji Pharmaceutical, Jiyuan Medicine, Jiren Medicinal Slices, Pudilan Daily Use Chemicals, Kangxuyuan Health Products, the Ginkgo Industry Research Institute, Oral Health Research Institute and Haiyuan Property.
Subsidiary Shanghai Jijia Investment Co Ltd has a number of its own subsidiaries, including Ningbo Jijia Investment and Dongke Pharmacy.
Jumpcan Pharmaceutical focuses on R&D, production and sales of drugs in fields including pediatrics, gynecology, pneumology, gastroenterology and geriatrics.
A factory that is being operated by Jumpcan Pharmaceutical Group. [Photo/WeChat ID: tzfabu]